10 Unusual Stocks Attracting Huge Interest In The Pre-Market Right Now

steve ballmer

Photo: AP

Here’s where we see the heat today:Microsoft is on fire, Micron announces a huge buyback, there’s a cascade of plays around an obesity drug, and more…

EARNINGS: Microsoft beat expectations last night, shares are surging

EARNINGS: Merck (MRK) revenue 'disappoints' and the company reports a huge charge

EARNINGS: Honda (HMC) meets expectations, but hikes guidance. Yet ADRs are falling pre-market.

EARNINGS: Sony both beat expectations and raised guidance in Japan today, but ADRs are weak

PHARMA CATALYST: The FDA has apparently rejected Vivus's (VVUS) weight loss drug, but JP Morgan has upgraded the shares

Peculiar situation. Read about the FDA rejection here, and JP's upgrade here.

PHARMA: Bad news for Vivus's drug is good news for competitor Orexigen (OREX), shares rising

PHARMA: It could also be good for collapsed Arena Pharma (ARNA), which is rising moderately

BUYBACK: Micron (MU) rising on high volume after announcing a major share buyback

EARNINGS: Spine treatment company NuVasive (NUVA) crashing after slashing guidance last night

EARNINGS: Power management company PowerOne (PWER) demolishes estimates, shares melting up

EARNINGS: Coinstar (CSTR) beats estimates, reports soaring DVD sales, stock up strong

EARNINGS: Pharma company AMAG finds safety problems with a drug, is cutting workforce, shares plummeting

EARNINGS: First Solar (FSLR) beats estimates, but says capex will double. Markets don't seem happy.

BP OIL SPILL: Halliburton (HAL) still falling after yesterday's news that they might have known cement measures were flawed around the Deepwater Horizon rig

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.